Lexicon Pharmaceuticals Inc
NASDAQ: LXRX
$1.67
+$0.01 (+0.6%)
Closing Price on July 5, 2024
LXRX Chart and Intraday Price
LXRX Company Data
| Asset Type | Stock |
| Exchange | NASDAQ |
| Currency | USD |
| Country | USA |
| Sector | LIFE SCIENCES |
| Industry | PHARMACEUTICAL PREPARATIONS |
| Address | 8800 TECHNOLOGY FOREST PLACE, THE WOODLANDS, TX, US |
| Fiscal Year End | December |
| Latest Quarter | 9/30/2023 |
| Market Cap | 605.18M USD |
| Shares Outstanding | 244,025,000 |
LXRX Articles
Friday's additional top analyst upgrades and downgrades were on Ciena, Lennar, Lexicon Pharmaceuticals, Mister Car Wash, PagerDuty, RealReal, Six Flags and more.
Published:
The Friday afternoon analyst calls were focused on Biogen, 3D Systems, Duke Energy, Ford, and more.
Published:
Lexicon Pharma shares jumped on Thursday morning after the company announced that it received regulatory feedback from the FDA regarding its heart failure treatment.
Published:
24/7 Wall St. has compiled a list of some speculative biotech plays that could see gains of up to 300% in the coming months.
Published:
Lexicon Pharmaceuticals shares surged on Tuesday after the company announced positive topline data for its late-stage studies in type 2 diabetes.
Published:
After Lexicon Pharmaceuticals announced the termination of its alliance with Sanofi, its shares rallied on Wednesday.
Published:
Lexicon Pharma shares were absolutely crushed on Monday after it was announced that Sanofi would be ending its partnership with the firm.
Published:
Lexicon shares jumped on Friday after the European Medicines Agency’s Committee for Medicinal Products for Human Use adopted a positive opinion on the Marketing Authorization of Zynquista...
Published:
Last Updated:
Vodafone, Lexicon Pharmaceuticals, Amneal Pharmaceuticals, and Maiden Holding had all posted new 52-week lows by noon Friday.
Published:
Last Updated:
Immunomedics, Signet Jewelry, Nautilus, and Lexicon Pharmaceuticals had all posted new 52-week lows by noon Friday.
Published:
Last Updated:
Lexicon shares fell on Friday after the FDA voted to approve the firm’s type 1 diabetes treatment. Although the result from this committee was mixed, it seems to be a case of sell the news.
Published:
Last Updated:
Here, 24/7 Wall St. has included a calendar of a few of companies to watch for in the coming week and the rest of June.
Published:
Last Updated:
Here 24/7 Wall St. has included a calendar of a few of companies to watch for in the coming week and the rest of June.
Published:
Last Updated:
The top analyst upgrades, downgrades and other research calls from Monday include American Electric Power, American Water Works, BHP Billiton, Boeing, Costco, Crocs, Dollar General, McDonald's and...
Published:
Last Updated:
These top picks from Wedbush offer varying degrees of risk and upside. The fact that they are not crowded momentum plays makes them far more attractive for the rest of 2017 and into next year.
Published:
Last Updated: